Status:
ENROLLING_BY_INVITATION
Paracetamol Plus Tramadol Versus Fentanyl As Preemptive Analgesia For Enhanced Recovery After Day Case Surgeries
Lead Sponsor:
Zagazig University
Conditions:
Preemptive Paracetamol Plus Tramadol and Preemptive Fentanyl
Eligibility:
All Genders
21-65 years
Phase:
EARLY_PHASE1
Brief Summary
Implementation of enhanced recovery in day case surgeries using either preemptive intravenous paracetamol plus tramadol or preemptive intravenous fentanyl.
Detailed Description
after being informed about the study and potential risks. All patients giving written consent will be randomized by double blind manner into two equal groups (T group and F group). Using computer gene...
Eligibility Criteria
Inclusion
- Patients scheduled for day case surgeries.
- Patient acceptance to be included into the study.
- Both sex.
- Patients with ASA physical status I, II.
- BMI 25 - 30 kg m-2.
- Duration of surgery from 1-2 hours
Exclusion
- Uncooperative patients and patients with psychological problems.-
- Patients with liver or renal impairment.
- Patients with history of allergy to drug used in the study.
- Patients with chronic pain.
- Patient on pain therapy.
Key Trial Info
Start Date :
September 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 20 2025
Estimated Enrollment :
102 Patients enrolled
Trial Details
Trial ID
NCT06561672
Start Date
September 1 2024
End Date
June 20 2025
Last Update
August 20 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Aculty of Medicine,Zagazig University
Zagazig, Sharqia Province, Egypt, 44519